Overhauling Compliance and GMPs

April 2, 2003
Jill Wechsler
Pharmaceutical Technology

Volume 27, Issue 4

FDA's newly launched risk-based approach to GMP regulation spurs signficant changes in the agency's approach to inspection processes, postapproval changes, and 21 CFR Part 11 enforcement.